Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment? | Value Health;17(7): A460, 2014 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Which Adverse Effects Influence the Dropout Rate in Selective Serotonin Reuptake Inhibitor (Ssri) Treatment?

Kostev, K; Ehlken, B; Rex, J; Engelhard, J; Altmann, V; Heilmaier, C.

Affiliation

Kostev K; IMS Health, Frankfurt am Main, Germany.
Ehlken B; IMS Health Germany, Munich, Germany.
Rex J; IMS Health, Frankfurt am Main, Germany.
Engelhard J; IMS Health, Frankfurt am Main, Germany.
Altmann V; IMS Health, Frankfurt am Main, Germany.
Heilmaier C; FOM University of Applied Sciences, Essen, Germany.

Value Health ; 17(7): A460, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27201286

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Germany

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Germany